Soluble Biotech

From Bhamwiki
Revision as of 11:30, 2 October 2014 by Dystopos (talk | contribs)
Jump to navigation Jump to search
Soluble Therapeutics logo.png

Soluble Therapeutics LLC is a company that specializes in analyzing protein formulations and establishing improvements to their solubility characteristics as a service to the pharmaceutical research industry. The company uses a proprietary system to conduct analyses quickly and efficiently. The company was founded in 2008 as a spinoff of research performed at UAB. Joseph Garner was hired as CEO in 2010 to lead business development efforts. In 2012 the company was awarded a $1 million grant to help commercialize its technology for sale.

The company is housed at the Innovation Depot in downtown Birmingham.

In 2014 Soluble Therapeutics acquired Dilyx Biotechnologies of Seattle, Washington.

This article is a stub. You can help Bhamwiki by expanding it.

References

  • Swant, Martin (June 17, 2012) "Birmingham biotech company wins National Institutes of Health $1 million grant." The Birmingham News
  • Hoppe, Ian (July 30, 2014) "Birmingham is on the front lines of medical research: take a look at this biotech startup." The Birmingham News
  • Hoppe, Ian (October 2, 2014) "Birmingham's Soluble Therapeutics acquires Seattle company Dilyx Biotechnology." The Birmingham News

External links

Retrieved from "http://bhamwiki.com/w/index.php?title=Soluble_Biotech&oldid=109115"